Skip to content
Search

Latest Stories

India's Chhetri says no comparisons with Messi

India's Sunil Chhetri said Wednesday comparisons with Lionel Messi are misplaced after overtaking him in number of goals, and added he remains a huge fan of the Argentine star.

Chhetri surpassed Messi's tally of 72 international goals in India's 2-0 win over Bangladesh on Monday to stand behind top-ranked Cristiano Ronaldo (103) among active players.


"The fact is there is no comparison whatsoever (with Messi)," Chhetri, who has scored 74 international goals, said from Doha.

"When anyone sees those (top goal scorer) chart, be happy for five seconds as an Indian and that's about it. Forget about me and Messi because the whole world, including me, is a fan of Messi."

Chhetri, 36, scored all two goals in India's victory in the qualifying match for the 2022 FIFA World Cup and 2023 AFC Asian Cup.

With 73 strikes Ali Mabkhout, of the United Arab Emirates, is also above Messi -- a six-time Ballon d'Or winner widely regarded as the greatest player of the modern era.

India, who are ranked 105th in the FIFA team rankings, are already out of the race to qualify for the World Cup but can make it to the Asian Cup in China.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less